Entity
Dr
Dr is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.
Latest on Dr
- Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
- STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
- The next big thing in hydrogen could be underground
- Walmart’s stock slides as U.S. sales are hit by falling drug prices
- Treasury’s buyback blitz may end up driving bond yields higher, warns JPMorgan. Here’s its advice for investors.
- Autonomy’s New CEO Is Going After the Drivers Leases Don’t Fit
Connections
9 entities linked to Dr across the news graph.